Table 2.
List of some of the AMPs that can be used in cancer therapeutic studies [158].
| AMPs | Source | Significance | Ref. |
|---|---|---|---|
| Poca A, Poca B and CyO4 | Pombalia calceolaria | Reduced the breast cancer cell up to 80% | [185] |
| Aurein 1.2 | Frog Litoria aurea | Among 54 cancer cells, 52 are inhibited in NCI testing method | [186] |
| Bmattacin2 | Bombyx mori | Disrupted A375 and HCT116 cancer cells | [187] |
| Laterosporulin10 | Brevibacillus sp. | MCF-7, H1299, HEK293T, HT1080, and HeLa cancer cells were disrupted | [188] |
| Dermaseptin-PD-1 and dermaseptin-PD-2 | Phyllomedusine leaf frogs | Growth of H157, PC-3, and U251 MG cancer cell was inhibited | [189] |
| Scolopendrasin VII | Centipede | Reduction in the viability of leukaemia cells | [190] |
| Myristoyl-CM4 | Synthetic | Activates caspase 9, caspase 3, and cleavage of Poly(ADP-ribose) polymerase (PARP) in breast cancer cells | [191] |
| K4R2-Nal2-S1 | Synthetic | Binds with lung cancer cells and results in apoptosis | [192] |
| VLL-28 | Sulfolobus islandicus | Inhibits murine and human tumour cells | [193] |
| CopA3 | Copris tripartitus | Reduction in cell viability of gastric cancer cells | [194] |
| Pardaxin | Pardachirus armoratus | Improved the activation of caspase-3 | [195] |